Key result
Chronic preoperative beta-blockers show no association with reduced POAF after elective ascending aortic surgery.
Why the study?
Postoperative atrial fibrillation is a frequent complication of cardiac surgery, but the efficacy of commonly used b-blockers for its prevention in patients undergoing elective ascending aorta surgery remains unclear.
Does chronic preoperative beta-blocker therapy prevent postoperative atrial fibrillation in adult patients undergoing elective surgical aneurysm repair of the ascending aorta?
Observational (n=214)
No
Does chronic preoperative beta-blocker therapy prevent postoperative atrial fibrillation in adult patients undergoing elective surgical aneurysm repair of the ascending aorta?
Chronic preoperative beta-blocker therapy does not significantly reduce the incidence of postoperative atrial fibrillation in patients undergoing elective ascending aortic surgery.
Answers are grounded in this paper and cite their sources.
Preoperative beta-blockers were not associated with reduced POAF; leaves open alternative prophylaxis strategies pending RCT confirmation.
BACKGROUND: Postoperative atrial fibrillation (POAF) is a frequent complication following cardiac surgery and is associated with increased morbidity and mortality. Although b-blockers are commonly used for POAF prevention, their efficacy in patients undergoing elective surgery of the ascending aorta remains unclear. AIMS: We aimed to evaluate the impact of chronic preoperative b-blocker therapy on the occurrence of POAF in patients undergoing elective ascending thoracic aortic surgery. SETTINGS AND DESIGN: This single-center, retrospective observational study included adult patients who underwent elective surgical aneurysm repair of the ascending aorta between 2012 and 2021. MATERIALS AND METHODS: Patients with a documented history of paroxysmal, persistent, or permanent atrial fibrillation were excluded. Acute aortic dissection cases were also excluded. STATISTICAL ANALYSIS: Associations between preoperative b-blockers therapy and POAF, as well as postoperative clinical outcomes, were assessed using Chi-square tests and independent-samples t-tests. RESULTS: A total of 214 patients were included in the analysis. POAF occurred in 46% of patients. Chronic preoperative b-blocker therapy was not significantly associated with the development of POAF (P = 0.058). Among postoperative outcomes, stroke was significantly more frequent in patients who developed POAF (P = 0.026), whereas no significant associations were observed with acute kidney injury, renal replacement therapy, reintubation, or in-hospital mortality. CONCLUSIONS: In patients undergoing elective ascending aortic surgery, chronic preoperative b-blocker therapy was not significantly associated with a reduced incidence of POAF. These findings suggest that POAF risk in aortic surgery may be influenced by factors beyond conventional pharmacological prophylaxis.
No takes yet. Share an insight, caveat, or question.
Ampatzidou et al. (2026) conducted an observational in Elective ascending thoracic aortic surgery (n=214). Chronic preoperative b-blocker therapy vs. No chronic preoperative b-blocker therapy was evaluated on Postoperative atrial fibrillation (POAF) (p=0.058). Chronic preoperative b-blocker therapy was not associated with a reduced incidence of postoperative atrial fibrillation in patients undergoing elective ascending aortic surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: